[1] Dudakov JA,Hanash AM,van den Brink MR.Interleukin-22:immunobiology and pathology[J].Annu Rev Immunol,2015,33:747-785.[2] Sabat R,Ouyang W,Wolk K.Therapeutic opportunities of the IL-22-IL-22R1 system[J].Nat Rev Drug Discov,2014,13(1):21-38.[3] Jiang R,Tan Z,Deng L,et al.Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 [J].Hepatology,2011,54(3):900-909.[4] Qin S,Ma S,Huang X,et al.Th22 cells are associated with hepatocellular carcinoma development and progression[J].Chin J Cancer Res,2014,26(2):135-141.[5] Zenewicz LA,Yancopoulos GD,Valenzuela DM,et al.interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation[J].Immunity,2007,27(4):647-659.[6] Feng D,Kong X,Weng H,et al.Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection[J].Gastroenterology,2012,143(1):188-198.[7] Sertorio M,Hou X,Carmo RF,et al.IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections[J].Hepatology,2015,61(4):1321-1331.[8] Radaeva S,Sun R,Pan HN,et al.Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis:IL-22 is a survival factor for hepatocytes via STAT3 activation[J].Hepatology,2004,39(5):1332-1342.[9] Brand S,Dambacher J,Beigel F,et al.IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro[J].Am J Physiol Gastrointest Liver Physiol,2007,292(4):G1019-G1028.[10] Feng D,Wang Y,Wang H,et al.Acute and chronic effects of IL-22 on acetaminophen-induced liver injury[J].J Immunol,2014,193(5):2512-2518.[11] Matsumoto A,Kanai T,Mikami Y,et al.IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis[J].PLoS One,2013,8(4):e62853.[12] Ki SH,Park O,Zheng M,et al.Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding:role of signal transducer and activator of transcription 3[J].Hepatology,2010,52(4):1291-1300.[13] Rolla S,Alchera E,Imarisio C,et al.The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice[J].Clin Sci,2016,130(3):193-203.[14] Chestovich PJ,Uchida Y,Chang W,et al.Interleukin-22:implications for liver ischemia/reperfusion injury[J].Transplantation,2012,93(5):485-492.[15] Gao B,Wang H,Lafdil F,et al.STAT proteins - key regulators of anti-viral responses,inflammation,and tumorigenesis in the liver[J].J Hepatol,2012,57(2):430-441. |